Loading clinical trials...
Loading clinical trials...
Glycogen storage disease type III (GSD-III) or Cori/Forbes disease, is caused by autosomal recessive mutations in the AGL gene, which codes for the glycogen debranching enzyme (GDE) involved in the re...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Institut de Myologie, France
NCT04990388 · Glycogen Storage Disease Type III
NCT02448667 · Glycogen Storage Disease Type III
NCT05196165 · Glycogen Storage Disease Type III
NCT02385162 · Fructose Metabolism, Inborn Errors, Glycogen Storage Disease, and more
NCT02054832 · Glycogen Storage Disease Type IA, Glycogen Storage Disease Type IB, and more
Aphp Antoine Beclere
Clamart
CHU du Kremlin-Bicêtre
Le Kremlin-Bicêtre
Institue of Myology
Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions